February 19, 2025
Rosenau Family Research Foundation (RFRF) would like to extend its congratulations to its 2024 class of grant recipients!
The mission and vision of RFRF is improving the lives of patients impacted by Krabbe disease and Cystic Fibrosis through research funding and disease advocacy, and helping individuals live life undefined by Krabbe disease and Cystic Fibrosis.
To support this mission and vision, the foundation considers grant funding for basic science research, translational research, and clinical research that can lead to or enhance treatments and cures for Krabbe disease and Cystic Fibrosis. Programs that promote, through education and awareness, the expansion of Newborn Screening, Krabbe disease, and Cystic Fibrosis are similarly considered.
“The 2024 funded grants continue a legacy of excellent research being done in the fields of Krabbe disease and Cystic Fibrosis,” said RFRF Executive Director, Gabriel M Cohn, MD, MBA. ”Our grant recipients also include one new investigator, which is exciting to us as an organization as we work to recruit greater participation in rare disease research.”
2024 Grant Recipients
Each full grant application is evaluated by RFRF’s Scientific Advisory Committee (SAC) for alignment with RFRF’s goals and objectives, as well as the proposal’s scientific merit, significance, robustness, and feasibility (scientific, technical, and financial).
Only grant applications that address specific scientific question(s) or applications that address specific educational/awareness goal(s) and that are aligned with RFRF’s mission and vision are funded.
The next RFRF grant cycle begins with a Letter of Intent submission period from 5/1/2025 – 7/31/2025.
To learn more about this and past year’s grant recipients, visit rosenaufoundation.org/funded-grants.